Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit

OBJECTIVES: To investigate the prognostic significance of the systemic immune-inflammation index (SII) in patients after radical cholecystectomy for gallbladder cancer (GBC) using overall survival (OS) as the primary outcome measure. METHODS: Based on data from a multi-institutional registry of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Ren, Tai, Liu, Ke, Li, Mao-Lan, Geng, Ya-Jun, Yang, Yang, Li, Huai-Feng, Li, Xue-Chuan, Bao, Run-Fa, Shu, Yi-Jun, Weng, Hao, Gong, Wei, Lau, Wan Yee, Wu, Xiang-Song, Liu, Ying-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276054/
https://www.ncbi.nlm.nih.gov/pubmed/34268122
http://dx.doi.org/10.3389/fonc.2021.692647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276054/
https://www.ncbi.nlm.nih.gov/pubmed/34268122
http://dx.doi.org/10.3389/fonc.2021.692647

Ejemplares similares